RFK Jr. Criticizes Pregnant Moms Taking Tylenol to Protest Trump as ‘Pathological’
During the White House’s monthly Cabinet meeting, Health and Human Services Secretary Robert F. Kennedy Jr. publicly condemned a growing trend of pregnant mothers taking Tylenol to protest President Donald Trump, labeling the act as ‘pathological.’ Kennedy argued that this behavior, he claims, represents a dangerous level of ‘Trump derangement syndrome,’ where individuals are said to be driven by an irrational fixation on the former president. He highlighted a video of a Columbia medical professor ingesting Tylenol on TikTok, expressing concern over the potential risks to maternal and fetal health.
Kennedy’s comments align with recent claims by the administration that Tylenol could be linked to autism, with Trump himself making the assertion during a September address. The Health and Human Services Secretary pointed out that researchers have long suspected a connection between the over-the-counter pain medication and rising autism rates, which have seen a dramatic surge over recent decades. He argued that the administration is now taking a more comprehensive approach to investigating the issue by breaking down traditional silos among various federal agencies.
Kennedy criticized the National Institutes of Health (NIH) for historically focusing on genetic research rather than exploring environmental or medical factors. He suggested that this approach has been ‘politically safe and entirely fruitless.’ Meanwhile, the Tylenol manufacturer, Kenvue, has publicly denied these claims, stating that independent scientific studies clearly show no link between acetaminophen and autism. This has sparked a broader debate over the role of pharmaceuticals in public health and the political implications of such research.
The controversy has also drawn attention to the broader implications for maternal and child health, with critics arguing that the administration’s stance on this issue is based on incomplete or misleading information. The growing divide between political figures and scientists highlights ongoing tensions over the interpretation and application of medical research in public policy. As the debate continues, both sides maintain their positions, with some calling for more transparent and evidence-based discussions.